His main research concerns Cancer research, Pancreatic cancer, Internal medicine, Adenocarcinoma and Cancer. His Cancer research research is multidisciplinary, relying on both Cell culture, Cell growth, Pathology, Regulation of gene expression and Pancreatic disease. His Pancreatic cancer study combines topics in areas such as Cancer cell, Cancer stem cell, Transcription factor, Pancreas and Chemoradiotherapy.
His Internal medicine research incorporates elements of Gastroenterology and Oncology. The Adenocarcinoma study combines topics in areas such as Surgery, Radiation therapy and Pancreaticoduodenectomy. His Cancer research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Epigenetics.
His primary areas of investigation include Cancer research, Pancreatic cancer, Internal medicine, Oncology and Pathology. His Cancer research research includes elements of Cell growth, Carcinogenesis, Cancer cell, Immunology and KRAS. His Pancreatic cancer study is related to the wider topic of Cancer.
His study looks at the relationship between Internal medicine and fields such as Gastroenterology, as well as how they intersect with chemical problems. His research integrates issues of Irinotecan, Pancreatic ductal adenocarcinoma, Gemcitabine, Survival analysis and Cohort in his study of Oncology. His Pathology research includes themes of Metastasis, Pancreatitis and Pancreas.
Cancer research, Pancreatic cancer, Internal medicine, Cancer cell and Tumor progression are his primary areas of study. His Cancer research study incorporates themes from Carcinogenesis, KRAS, Oncogene and In vivo. Cancer covers he research in Pancreatic cancer.
The study incorporates disciplines such as Gastroenterology and Oncology in addition to Internal medicine. Huamin Wang interconnects Apoptosis, Small hairpin RNA, Null cell, Gene and Sterol regulatory element-binding protein in the investigation of issues within Cancer cell. His Tumor progression research incorporates themes from Phenotype, STAT3, STAT protein and Immunohistochemistry.
Huamin Wang focuses on Pancreatic cancer, Cancer research, Cancer cell, Tumor microenvironment and Pancreatic tumor. His Pancreatic cancer study is focused on Internal medicine in general. His work deals with themes such as Carcinogenesis, KRAS, Erlotinib, EGFR inhibitors and RNase P, which intersect with Cancer research.
The concepts of his Cancer cell study are interwoven with issues in Oncogene and Pancreas. His Pancreas research focuses on Transcription factor and how it relates to Cancer. He has included themes like Progenitor cell and Radiology in his Pancreatic tumor study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Andrea Viale;Piergiorgio Pettazzoni;Costas A. Lyssiotis;Haoqiang Ying.
Nature (2014)
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Thiruvengadam Arumugam;Vijaya Ramachandran;Keith Francis Fournier;Huamin Wang.
Cancer Research (2009)
Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy
Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong.
Annals of Surgical Oncology (2006)
Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)
Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
Dan G. Blazer;Yoji Kishi;Dipen M. Maru;Scott Kopetz.
Journal of Clinical Oncology (2008)
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang.
Annals of Surgery (2007)
Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer
Avnish Kapoor;Wantong Yao;Haoqiang Ying;Sujun Hua.
Cell (2014)
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun.
Annals of Surgical Oncology (2009)
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun.
Journal of Clinical Oncology (2008)
KrasG12D-Induced IKK2/β/NF-κB Activation by IL-1α and p62 Feedforward Loops Is Required for Development of Pancreatic Ductal Adenocarcinoma
Jianhua Ling;Ya'an Kang;Ruiying Zhao;Qianghua Xia.
Cancer Cell (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Duke University
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Medical College of Wisconsin
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Klagenfurt
National University of Singapore
Aix-Marseille University
École Polytechnique Fédérale de Lausanne
Johns Hopkins University
University of Koblenz and Landau
University of Freiburg
Kyoto University
University of Helsinki
Yunnan University
Stanford University
University of South Florida
University of Bamberg
McGill University
Mario Negri Institute for Pharmacological Research
Queens College, CUNY